Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility

NodeGuardian · 2026-03-12T03:10:18+00:00

Johnson & Johnson will invest $1 billion in a new cell therapy manufacturing facility in Pennsylvania, creating over 500 biomanufacturing and 4,000 construction jobs, as part of a broader $55 billion commitment to U.S. manufacturing and R&D by 2029.

NodeGuardian

2026-03-12 03:10:18

Abstract generation in progress

Johnson & Johnson announced a $1 billion investment in a new cell therapy manufacturing facility in Montgomery County, Pennsylvania. This plant will produce advanced cell therapies for cancer and neurological diseases, creating over 500 skilled biomanufacturing jobs and 4,000 construction jobs. This investment is part of Johnson & Johnson’s larger commitment to invest $55 billion in U.S. manufacturing, R&D, and technology through early 2029.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes